Top News

The Gores Group Completes Therakos Acquisition

Los Angeles-based private equity firm The Gores Group said today that it has completed the acquisition of Therakos, a New Jersey-based firm which provides systems used for immunomodulatory therapy. Financial terms of the buy were not announced. Therakos was part of Ortho-Clinical Diagnostics, Inc. Gores has named Michael Rechtiene as CEO of Therakos as part of the acquisition. Gores originally announced the acquisition in October.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel